This study evaluates serum ANKRD22 and SERPING1 as potential biomarkers of drug resistance through comparative analysis of expression profiles in drug-resistant versus drug-sensitive tuberculosis patients. This evidence concerns the gene ANKRD22 and tuberculosis.